Bioavailability is the fraction of an administered dose that reaches systemic circulation in active form. Peptides generally have low oral bioavailability because they are degraded in the gut, which is why most are studied via injectable routes.
Research use only. This definition is an educational reference, not medical advice or dosing guidance.